Delcath Systems Announces An Independent Investigator Presentation At The Cardiovascular And Interventional Radiological Society Of Europe Annual Meeting
A Retrospective Comparative Study of SIRT and CS-PHP for Liver Targeted Therapy of Patients with Metastatic Uveal Melanoma
NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ:DCTH), an